Working… Menu

ERCP in Idiopathic Recurrent Acute Pancreatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01583517
Recruitment Status : Completed
First Posted : April 24, 2012
Last Update Posted : October 10, 2014
Information provided by (Responsible Party):
Indiana University

Brief Summary:
The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators conducted a single center, feasibility, randomized trial to determine 1) the role of pancreatic manometry in predicting future episodes of RAP and 2) differences in the efficacy of no, biliary (BES) or pancreatobiliary (dual) endoscopic sphincterotomy (DES).

Condition or disease Intervention/treatment Phase
Recurrent Acute Pancreatitis Procedure: Biliary sphincterotomy Procedure: Pancreatobiliary sphincterotomy Procedure: Sham Not Applicable

Detailed Description:

Patients with idiopathic RAP, defined as ≥2 unexplained (per the treating physician) episodes of acute pancreatitis (based on standard criteria) requiring hospitalization, will be prospectively enrolled. All patients will undergo ERCP with manometry, with stratified randomization based on the assessment of pancreatic basal sphincter pressure. If <40mmHg, the patient will be randomized to sham or biliary sphincterotomy (BES). If ≥40mmHg, the patient will be randomized to BES or pancreatobiliary ("dual") sphincterotomy (DES).

Patients and physicians will not be blinded to the assignment group. Patients will be followed for up to 10 years to determine 1) incidence of RAP requiring hospitalization (using standard definitions) or 2) interval development of chronic pancreatitis (CP).

Differences between patients who did and did not develop RAP during follow-up will be compared to evaluate for factors associated with AP during follow-up.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 89 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Defining the Role of ERCP in the Evaluation and Treatment of Idiopathic Recurrent Acute Pancreatitis
Study Start Date : September 1997
Actual Primary Completion Date : April 2012
Actual Study Completion Date : October 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pancreatitis

Arm Intervention/treatment
Active Comparator: Biliary sphincterotomy
Cutting of the biliary sphincter muscle alone
Procedure: Biliary sphincterotomy
Cutting of the biliary sphincter muscle.

Active Comparator: Dual sphincterotomy
Cutting of both the biliary and pancreatic sphincter muscles.
Procedure: Pancreatobiliary sphincterotomy
Cutting of both the biliary and pancreatic sphincter muscles.

Sham Comparator: Sham
Among patients with normal sphincter of Oddi manometry, patients will undergo no sphincterotomy (sham therapy).
Procedure: Sham
No sphincterotomy is performed in patients randomized to sham with normal SOM.

Active Comparator: Biliary sphincterotomy - Normal SOM
Among patients with normal SOM, patients may be randomized to empiric biliary sphincterotomy alone.
Procedure: Biliary sphincterotomy
Cutting of the biliary sphincter muscle.

Primary Outcome Measures :
  1. Recurrent acute pancreatitis [ Time Frame: 120 months ]

    Patients will be followed post-ERCP for up to 10 years. The primary outcome is development of acute pancreatitis following the index ERCP, based on standard definitions.

    Acute pancreatitis is defined as new onset of pancreatic-type abdominal pain with associated elevation in serum amylase or lipase > 3 times the upper limit of normal, OR radiographic findings consistent with acute pancreatitis.

Secondary Outcome Measures :
  1. Interval development of chronic pancreatitis [ Time Frame: 120 months ]
    Determine the incidence of chronic pancreatitis during prolonged follow-up. Chronic pancreatitis is defined as characteristic changes on cross sectional imaging (CT or MRI/MRCP) or ERP (Cambridge classification).

  2. Secondary assessment of risk factors for developing recurrent acute pancreatitis during follow-up [ Time Frame: 120 months ]
    A post hoc analysis will be conducted to evaluate for independent factors associated with having recurrent acute pancreatitis during follow-up

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Idiopathic recurrent acute pancreatitis, defined as two or more episodes requiring hospitalization
  • ERCP with SOM planned

Exclusion Criteria:

  • Chronic pancreatitis
  • Pancreas divisum
  • Alternate etiology identified (e.g., CBD stone, IPMN)
  • Inability to perform pancreatic manometry
  • Pregnancy, age < 18, incarceration
  • Inability to provide informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01583517

Layout table for location information
United States, Indiana
Indiana University Health University Hospital
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Layout table for investigator information
Principal Investigator: Stuart Sherman, MD Indiana University
Publications of Results:
Layout table for additonal information
Responsible Party: Indiana University Identifier: NCT01583517    
Other Study ID Numbers: 1011003897
First Posted: April 24, 2012    Key Record Dates
Last Update Posted: October 10, 2014
Last Verified: October 2014
Keywords provided by Indiana University:
Acute pancreatitis
Sphincter of Oddi dysfunction
Additional relevant MeSH terms:
Layout table for MeSH terms
Pancreatic Diseases
Digestive System Diseases